Surgery Partners Quarterly Income Statement
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Surgery Partners revenue and earnings
In the quarter ended Jun 30, 2026, Surgery Partners generated $848.9 million in revenue, up 2.7% from the same quarter a year earlier. Surgery Partners reported a net loss of $15.0 million, compared with a loss of $2.5 million a year earlier. Operating margin was 12.0%.
Diluted earnings per share came in at -$0.12.
Summary generated from market data by MetaCap's automated system. Methodology
Surgery Partners income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 848.90M | 810.90M | 885.00M | 821.50M | 826.20M | 776.00M | 864.40M | 770.40M | 762.10M | 717.40M | 735.40M | 674.10M |
| Revenue growth (YoY) | +2.75% | +4.50% | +2.38% | +6.63% | +8.41% | +8.17% | +17.54% | +14.29% | +14.16% | +7.69% | +4.00% | +8.62% |
| Operating Expenses | 746.80M | 745.10M | 774.80M | 715.80M | 714.50M | 714.10M | 737.30M | 709.50M | 677.30M | 641.40M | 634.00M | 591.50M |
| Operating Income | 102.10M | 65.80M | 110.20M | 105.70M | 111.70M | 61.90M | 127.10M | 60.90M | 84.80M | 76.00M | 101.40M | 82.60M |
| Other Income (Expense) | — | — | — | — | — | — | — | 700.00K | -4.80M | 400.00K | 900.00K | 1.20M |
| Pretax Income | 32.30M | -3.30M | 42.60M | 30.80M | 43.80M | -300.00K | 74.20M | 10.90M | 33.30M | 28.70M | 52.70M | 32.80M |
| Income Tax | 2.60M | -1.20M | 13.60M | 5.50M | -1.10M | 0 | 120.80M | 4.50M | 4.90M | 4.40M | 6.00M | 3.10M |
| Net Income | -15.00M | -35.90M | -15.00M | -22.70M | -2.50M | -37.70M | -108.50M | -31.70M | -15.50M | -12.40M | -1.00M | -4.90M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | -182.01% | — | — | — |
| EPS (Basic) | -0.12 | -0.28 | -0.11 | -0.18 | -0.02 | -0.30 | -0.86 | -0.25 | -0.12 | -0.10 | 0.00 | -0.04 |
| EPS (Diluted) | -0.12 | -0.28 | -0.11 | -0.18 | -0.02 | -0.30 | -0.86 | -0.25 | -0.12 | -0.10 | 0.00 | -0.04 |
| Shares Outstanding (Basic) | 128.82M | 128.37M | — | 127.21M | 126.98M | 126.60M | — | 126.17M | 126.13M | 125.97M | — | 125.75M |
| Shares Outstanding (Diluted) | 128.82M | 128.37M | — | 127.21M | 126.98M | 126.60M | — | 126.17M | 126.13M | 125.97M | — | 125.75M |
| EBITDA | 141.40M | 104.30M | 170.10M | 145.20M | 152.00M | 98.20M | 161.00M | 111.10M | 119.60M | 109.70M | 132.50M | 111.50M |
| Operating Margin | 12.03% | 8.11% | 12.45% | 12.87% | 13.52% | 7.98% | 14.70% | 7.90% | 11.13% | 10.59% | 13.79% | 12.25% |
| Net Margin | -1.77% | -4.43% | -1.69% | -2.76% | -30.00% | -4.86% | -12.55% | -4.11% | -2.03% | -1.73% | -14.00% | -73.00% |
This table shows 12 quarterly periods of Surgery Partners's income statement, from Q2 2026 back to Q3 2023, across 17 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow SGRY's reporting calendar. What is a income statement?